Literature DB >> 26959127

Subthreshold Diode Micropulse Laser: A Review.

Hilary S Brader1, Lucy H Y Young1.   

Abstract

The subthreshold diode micropulse laser is a form of non-damaging thermal laser therapy which has shown efficacy in multiple retinal conditions. The purpose of this article is to review the use of subthreshold diode micropulse laser as an emerging treatment modality for the treatment of retinal disease. The proposed mechanisms of action, safety, efficacy, recommended laser treatment parameters, and clinical applications for which the use of subthreshold diode micropulse laser has been studied will be reviewed.

Entities:  

Keywords:  Minimum-intensity; non-damaging; photocoagulation; subvisible

Mesh：

Year:  2016        PMID： 26959127     DOI： 10.3109/08820538.2015.1114837

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  13 in total

1.  Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema.

Authors:  Meltem Guzin Altınel; Banu Acikalin; Meryem Guler Alis; Gokhan Demir; Kemal Mert Mutibayraktaroglu; Ozgun Melike Gedar Totuk; Aylin Ardagil
Journal:  Lasers Med Sci       Date:  2021-04-04       Impact factor: 3.161

2.  Factors affecting the response to subthreshold micropulse laser therapy used in center-involved diabetic macular edema.

Authors:  Mehmed Uğur Işık; Mehmet Fatih Kağan Değirmenci; Ayhan Sağlık
Journal:  Lasers Med Sci       Date:  2021-10-17       Impact factor: 3.161

Review 3.  Long-term results of micropulse laser trabeculoplasty with 577-nm yellow wavelength in patients with uncontrolled primary open-angle glaucoma and pseudoexfoliation glaucoma.

Authors:  Sevda Aydin Kurna; Ayse Demirciler Sonmez; Murat Yamic; Ahmet Altun
Journal:  Lasers Med Sci       Date:  2022-03-30       Impact factor: 2.555

4.  Improved retinal and visual function following panmacular subthreshold diode micropulse laser for retinitis pigmentosa.

Authors:  Jeffrey K Luttrull
Journal:  Eye (Lond)       Date:  2018-02-16       Impact factor: 3.775

5.  Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser.

Authors:  Maciej Gawęcki; Agnieszka Jaszczuk-Maciejewska; Anna Jurska-Jaśko; Andrzej Grzybowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-08-22       Impact factor: 3.117

6.  Low incidence of choroidal neovascularization following subthreshold diode micropulse laser (SDM) in high-risk AMD.

Authors:  Jeffrey K Luttrull; Stephen H Sinclair; Solly Elmann; Bert M Glaser
Journal:  PLoS One       Date:  2018-08-23       Impact factor: 3.240

7.  Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial.

Authors:  Hatice Selen Kanar; Aysu Arsan; Ahmet Altun; Suat Fazıl Akı; Aynur Hacısalihoglu
Journal:  Indian J Ophthalmol       Date:  2020-01       Impact factor: 1.848

8.  Investigations on Retinal Pigment Epithelial Damage at Laser Irradiation in the Lower Microsecond Time Regime.

Authors:  Eric Seifert; Svenja Rebecca Sonntag; Philipp Kleingarn; Dirk Theisen-Kunde; Salvatore Grisanti; Reginald Birngruber; Yoko Miura; Ralf Brinkmann
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-03-01       Impact factor: 4.799

9.  Induction of Heat Shock Protein 70 in Mouse RPE as an In Vivo Model of Transpupillary Thermal Stimulation.

Authors:  Mooud Amirkavei; Marja Pitkänen; Ossi Kaikkonen; Kai Kaarniranta; Helder André; Ari Koskelainen
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

10.  Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy.

Authors:  Zuhua Sun; Ying Huang; Chaochao Nie; Zhijie Wang; Junqing Pei; Bing Lin; Rong Zhou; Junyan Zhang; Victor Chong; Xiaoling Liu
Journal:  Eye (Lond)       Date:  2019-11-29       Impact factor: 3.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.